Skip to main content
Log in

Effects of thromboxane A2 analogue on vascular resistance distribution and permeability in isolated blood-perfused dog lungs

  • Published:
Lung Aims and scope Submit manuscript

Abstract

This study was designed to determine the effects of thromboxane A2 (TxA2) on the distribution of vascular resistance, lung weight, and microvascular permeability in isolated dog lungs perfused at a constant pressure with autologous blood. The stable TxA2 analogue (STA2; 30 μg, n = 5) caused an increase in pulmonary capillary pressure (Pc) assessed as double-occlusion pressure to 14.0 ± 0.4 mmHg from the baseline of 7.9 ± 0.3 mmHg with progressive lung weight gain. Pulmonary vascular resistance increased threefold exclusively due to pulmonary venoconstriction. Pulmonary venoconstriction was confirmed in lungs perfused in a reverse direction from the pulmonary vein to the artery (n = 5), as evidenced by marked precapillary vasoconstriction and a sustained lung weight loss. Furthermore, in lungs perfused at a constant blood flow (n = 5), STA2 also caused selective pulmonary venoconstriction. Vascular permeability measured by the capillary filtration coefficient and the isogravimetric Pc at 30 and 60 min after STA2 infusion did not change significantly from baseline in any lungs studied. Moreover, elevation of Pc by raising the venous reservoir of the intact lobes (n = 5) to the same level as the STA2 lungs caused a greater or similar weight gain compared with the STA2 lungs. Thus, we conclude that TxA2 constricts selectively the pulmonary vein resulting in an increase in Pc and lung weight gain without significant changes in vascular permeability in isolated blood-perfused dog lungs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barman SA, Senteno E, Smith S, Taylor AE (1989) Acetylcholine's effect on vascular resistance and compliance in the pulmonary circulation. J Appl Physiol 67:1495–1503

    Google Scholar 

  2. Barnard JW, Ward RA, Adkins WK, Taylor AE (1992) Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance. J Appl Physiol 72:1845–1853

    Google Scholar 

  3. Bowers RE, Ellis EF, Brigham KL, Oates JA (1979) Effects of prostaglandin cyclic end operoxides on the lung circulation of unanesthetized sheep. J Clin Invest 63:131–137

    Google Scholar 

  4. Brigham KL, Duke S (1985) Prostaglandins and lung disease: adult respiratory distress syndrome. Semin Respir Med 7:11–16

    Google Scholar 

  5. Brigham KL, Meyrick B (1986) State of the art: endotoxin and lung injury. Am Rev Respir Dis 133:913–927

    Google Scholar 

  6. Drake R, Gaar KA, Taylor AE (1978) Estimation of the filtration coefficient of pulmonary exchange vessels. Am J Physiol 234:H266-H274

    Google Scholar 

  7. Garcia-Szabo RR, Peterson MB, Watkins WD, Bizios R, Kong DL, Malik AB (1983) Thromboxane generation after thrombin: protective effect of thromboxane synthetase inhibition on lung fluid balance. Circ Res 53:214–222

    Google Scholar 

  8. Klausner JM, Peterson IS, Goldman G, Kobzik L, Valeri CR, Shepro D, Hechtman HB (1989) Thromboxane A2 mediates increased pulmonary microvascular permeability following limb ischemia. Circ Res 64:1178–1189

    Google Scholar 

  9. Kubo K, Kobayashi T (1985) Effects of OKY-046, a selective thromboxane synthetase inhibitor, on endotoxin-induced lung injury in unanesthetized sheep. Am Rev Respir Dis 132:494–499

    Google Scholar 

  10. Littner MR, Lott FD (1989) Edema from cyclooxygenase products of endogenous arachidonic acid in isolated lung. J Appl Physiol 67:846–855

    Google Scholar 

  11. Loyd JE, Newman JH, English DE, Ogletree ML, Meyrick BD, Brigham KL (1983) Lung vascular effects of phorbol myristate acetate in awake sheep. J Appl Physiol 54:267–276

    Google Scholar 

  12. Mais DE, Saussy DL Jr, Chaikhouni A, Kochel PJ, Knapp KR, Hamanaka N, Halushka PV (1985) Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther 233:418–424

    Google Scholar 

  13. Malik AB (1983) Pulmonary microembolism. Physiol Rev 63:1114–1207

    Google Scholar 

  14. Morel DR, Zapol WM, Thomas SJ, Kitain EM, Robinson DR, Moss J, Chenoweth DE, Lowenstein E (1987) C5a and thromboxane generation associated with pulmonary vaso- and bronchoconstriction during protamine reversal of heparin. Anesthesiology 65:597–604

    Google Scholar 

  15. Oates JA, FitzGerald GA, Branch RA, Jackson EK, Knapp HR, Roberts LJ (1988) Clinical implication of prostaglandin and thromboxane A2 formation. N Engl J Med 319:689–698

    Google Scholar 

  16. Ogletree ML, Brigham KL (1980) Arachidonate raises vascular resistance but not permeability in lungs of awake sheep. J Appl Physiol 48:581–586

    Google Scholar 

  17. Parker JC, Townsley MI, Rippe B, Taylor AE, Thigpen J (1984) Increased microvascular permeability in dog lungs, due to high peak airway pressures. J Appl Physiol 57:1809–1816

    Google Scholar 

  18. Seeger W, Ernst CH, Walmrath D, Neuhof H, Roka L (1985) Influence of the thromboxane antagonist BM 13.177 on the arachidonic acid-induced increase in pulmonary vascular resistance and permeability in rabbit lungs. Thrombosis Res 40:793–805

    Google Scholar 

  19. Shibamoto T, Parker JC, Taylor AE, Townsley MI (1990) Derecruitment of filtration surface area in paraquat-injured isolated dog lungs. J Appl Physiol 68:1581–1589

    Google Scholar 

  20. Shibamoto T, Hayashi T Jr, Sawano F, Saeki Y, Matsuda Y, Kawamoto M, Koyama S (1992) Pulmonary vascular response to anaphylaxis in isolated canine lungs. Am J Physiol 263:R1024-R1029

    Google Scholar 

  21. Taylor AE, Parker JC (1985) Pulmonary interstitial spaces and lymphatics. In: Handbook of Physiology. The Respiratory System. Circulation and Nonrespiratory Functions. American Physiological Society, Bethesda, MD, pp 162–230

    Google Scholar 

  22. Townsley MI, Korthuis RJ, Taylor AE (1985) Effects of arachidonate on permeability and resistance in canine lungs. J Appl Physiol 58:206–210

    Google Scholar 

  23. Townsley MI, Korthuis RJ, Rippe B, Parker JC, Taylor AE (1986) Validation of double vascular occlusion method for Pc,i in the lung and skeletal muscle. J Appl Physiol 61:127–132

    Google Scholar 

  24. Wakerlin GE, Benson GV, Pearl RG (1991) A thromboxane analog increases pulmonary capillary pressure but not permeability in the perfused rabbit lung. Anesthesiology 75:475–480

    Google Scholar 

  25. Win R, Nadir HB, Harker L, Hilderbrandt J (1983) Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. J Clin Invest 72:911–918

    Google Scholar 

  26. Yoshimura K, Todd ML, Pier KG, Rubin LJ (1989) Role of venoconstriction in thromboxane-induced pulmonary hypertension and edema in lambs. J Appl Physiol 66:929–935

    Google Scholar 

  27. Yoshimura K, Todd ML, Pier KG, Rubin LJ (1989) Effects of a thromboxane A2 analogue and prostacyclin on lung fluid balance in newborn lambs. Circ Res 65:1409–1416

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Offprint requests to: T. Shibamoto

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shibamoto, T., Wang, H.G., Yamaguchi, Y. et al. Effects of thromboxane A2 analogue on vascular resistance distribution and permeability in isolated blood-perfused dog lungs. Lung 173, 209–221 (1995). https://doi.org/10.1007/BF00181873

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00181873

Key words

Navigation